Surgery: splint – brace – or bandage – Bandage structure – Skin laceration or wound cover
Reexamination Certificate
1999-03-01
2001-03-06
Brown, Michael A. (Department: 3764)
Surgery: splint, brace, or bandage
Bandage structure
Skin laceration or wound cover
C602S044000, C602S045000, C602S059000
Reexamination Certificate
active
06198017
ABSTRACT:
The invention relates to medicinal pressure-sensitive adhesives which adhere to both dry and wet skin, and to plasters provided with said adhesives.
The present invention especially relates to medicinal pressure-sensitive adhesives with excellent adhesion and with a water-vapor permeability (WVP) of at least 30,000 g·m
−2
·24 h
−1
(measured on a pressure-sensitive adhesive film with a weight of 40 g/m
2
) and to their use for the production of pressure-sensitive adhesive medical products, e.g. for emergency or sports medicine.
The term pressure-sensitive adhesive here denominates adhesives which adhere reversibly to the respective surface through exertion of pressure.
The water-vapor permeability is the amount of water which escapes from an inverted cup—sealed with the substrate and filled with water—through the substrate to be measured per area and time at an ambient climate of 40° C. and 20% relative humidity.
DE-OS 44 16 928 teaches wet adhesives on the basis of acrylate copolymers. Further components are emulsifiers containing quaternary ammonium groups, emulsifiers containing polyoxyalkylenes, polyvinyl carboxylic acid, tackifying resins and cross-linking agents. The disadvantages of the products manufactured according to this document are on the one hand that the adhesives only adhere well to moist skin if the skin is dried before application, and on the other hand that the emulsifiers containing quaternary ammonium groups are not cross-linked with the polymer backbone, so that they can be dissolved out in damp surroundings and have a cytotoxic effect. Also, the water-vapor permeability of 30,000 g·m
−2
·24 h
−1
described in said document, measured on a pressure-sensitive adhesive film with a weight of 30 g/m
2
, is in many cases insufficient.
EP 0 415 055 describes pressure-sensitive adhesives with the water-soluble salt of an uncrosslinked copolymer of an amino group-containing monomer and at least one alkyl(meth)acrylate.
The disadvantages of this adhesive are on the one hand that the adhesive characteristics of the thus produced adhesive depend very strongly on the residual moisture content, thus making a complicated controlling of the drying conditions necessary, and on the other hand that the adhesive has absorbed so much moisture after a longer wearing period that when the carrier material is pulled off of the skin, the adhesive completely remains on the skin and must be removed with much effort using a soap solution.
It is thus the object of the present invention to provide medicinal pressure-sensitive adhesives which adhere excellently to dry, moist and wet skin and at the same time avoid the above mentioned disadvantages such as the necessity of pre-drying the skin, cytotoxic components and adhesive residue upon removal, and which are also suited for longer wearing periods due to their high WVP of at least 30,000 g·m
−2
·24 h
−1
30,000 g·m
−2
·24 h
−1
, at a pressure-sensitive adhesive film weight of 40 g/m
2
.
These surprisingly good characteristics are achieved in the adhesive according to the present invention which is characterized by a mixture of
a) 20-50 wt-% of a hydrophilic (meth)acrylate copolymerizate containing tertiary amino groups,
b) 20-50 wt-% of a hydrophobic (meth)acrylate copolymerizate containing carboxyl groups,
c) 10-40 wt-% of one or more mono- or dicarboxylic acids,
d) 0-10 wt-% of a polyol, and
e) 0.02-0.5 wt-% of a cross-linking system reacting with at least one copolymerizate,
whereby the sum of components a to e equals 100 wt-%, with a water-vapor permeability of ≧30,000 g·m
−2
·24 h
−1
, measured on a pressure-sensitive adhesive film with a thickness of 40 &mgr;m.
The pressure-sensitive adhesive according to the invention adheres excellently to both dry and sweaty skin, it can be removed from the skin without residue, and it has such a high WVP that it enables a longer wearing period even in damp surroundings.
Eudragit® E 100 (Röhm Pharma) is an example for a hydrophilic methacrylate copolymerizate containing tertiary amino groups.
Durotak® 1050 (National Starch & Chemical) is an example for a hydrophobic acrylate copolymer containing carboxyl groups. Suitable carboxylic acids are lauric, myristic or palmitic acid, and suitable dicarboxylic acids are adipic, octanedioic or sebacic acid.
Glycerin is a polyol according to the invention.
Cross-linking agents are e.g. metal chelates, metal acid esters, polyisocyanates, epoxide resins, aziridine resins, and triazine resins.
A further object of the invention is the use of the pressure-sensitive adhesives according to the invention for the production of pressure-sensitive adhesive medical products e.g. for emergency, intensive care and sports medicine, and also for occlusive dressings such as e.g. transdermal systems. If necessary, the medical products can be sterilized by water vapor, y-irradiation or gassing with ethylene oxide.
The thus obtained pressure-sensitive adhesives were evaluated—coated onto polyurethane films with good breathing properties—by means of physical-technical tests such as WVP (the water-vapor permeability of the pressure-sensitive adhesive film is calculated according to the following formula:
1
WVP
total
=
1
WVP
polyurethane
film
+
1
WVP
adhesive
)
and testing of the adhesive strength on steel plates according to AFERA 4001 as well on a skin model of polyurethane. With this skin model, an adhesive strength is achieved which is, on average, approximately 2N/25 mm higher than the corresponding average value on human skin. This is valid basically regardless of whether the pressure-sensitive adhesive is based on natural or synthetic rubber, a solvent- or water-based acrylate copolymer, or a silicon.
The samples were further tested on the skin of twenty test persons following a given evaluation system by means of statistical analysis. Strips of 2.5 cm×5 cm were applied to the hairless inner section of the forearms (dry), and pieces of 3 cm×3 cm were applied to the freshly washed and dried (moist) and undried (wet) palms of the test persons. Apart from the subjective evaluation of the adhesive strength after 1 hour and after 24 hours, further evaluation criteria were the dermatological acceptability and a pain-free, residue-free removal. The statistical analysis of these tests, whereby a standard was always set at 100%, led to the result that products with the pressure-sensitive adhesives according to the invention adhere to dry and wet skin without problem, do not cause skin irritations, and can be removed practically without residue.
In the following, the present invention is described in more detail with the help of the following examples:
REFERENCES:
patent: 4420470 (1983-12-01), Otsuka et al.
patent: 4994267 (1991-02-01), Sablotsky
patent: 5785985 (1998-07-01), Czech et al.
patent: 41 26 230A (1993-02-01), None
patent: 44 16 928 C1 (1994-05-01), None
patent: 0 387 751 A2 (1990-12-01), None
patent: 0 701 822 A2 (1995-09-01), None
patent: WO 84/03937 (1984-10-01), None
Basedow Arno
Kura Frank
Seeger Kurt
Brown Michael A.
Hamilton Lalita M.
Law Offices of Jane Massey Licata
Lohmann GmbH & Co. KG
LandOfFree
Medical pressure-sensitive adhesives with high permeability... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medical pressure-sensitive adhesives with high permeability..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medical pressure-sensitive adhesives with high permeability... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2518681